Post-IPO Equity Medical Companies

OssDsign is a medical-technology company developing implants for bone replacement.

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.

Audientes is engaged in the design and development of accessible and affordable hearing aids for hearing impaired people.

NewGenIvf Group is a healthcare services company that provides chromosome screening, embryo transfer, egg freezing, and IVF treatments.

Blueberries Medical is a producer of medicinal cannabis products.

ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases.

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

Psyence Biomedical is a life science biotechnology company that focuses on advancement of psychedelic medicines.

Captiva Verde is a cannabis manufacturing company that specializes in creating cannabis for recreational use and medicinal products.

Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.

Lumito is a medical device and technology licensing company located in Lund, Skane County, Sweden.

Biora Therapeutics is the biotech company.

ASEP Medical develops a diagnostic assay for the early and rapid diagnosis of sepsis.

Allied produces premium craft cannabinoid health products that support PTSI patients.

Carvolix is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Monogram Orthopaedics is a producer of surgical robotic equipment.

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

HealthLynked focuses on improving healthcare services.

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.